Bispecific Antibodies for Diffuse Large B-cell Lymphoma with Lorenzo Falchi, MD

Hannah joined HealthTree Foundation as the Lymphoma Education Manager in 2024. She is a Certified Health Education Specialist and is passionate about helping patients feel empowered through education and connection. Before joining HealthTree, Hannah worked in healthcare policy helping patients advocate for better care, research, and funding.

Dr. Falchi earned his MD degree Cum Laude and a board certification in Medical Oncology Cum Laude at the University of Perugia, Italy. He subsequently completed a postdoctoral fellowship at MD Anderson Cancer Center in Houston, TX, medicine residency at Yale-New Haven Hospital in New Haven, CT, and Hematology/Oncology fellowship at Columbia University Irving Medical Center in New York, NY. He is board certified in Internal Medicine, Hematology and Medical Oncology and is currently an Assistant Attending in the Lymphoma Service and Cellular Therapy Service at Memorial Sloan-Kettering Cancer Center and an Assistant Professor of Medicine at Weill Cornell Medical College, both in New York, NY. Dr. Falchi’s areas of interest include non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma. His current research is focused on the use of immunotherapy for the treatment of patients with B-cell NHL through the conduct of clinical and translational studies. He is the lead investigator in multiple national and global immunotherapy trials for patients with B-cell NHL. He authored or co-authored over 60 articles published in peer-reviewed journals, as well as numerous abstracts and several book chapters. His work has received extensive coverage by media outlets, including The New York Times Magazine, Thomson Reuters and other press agencies. Dr. Falchi is Co-Editor-In-Chief of Oncoimmunology, Associate Editor for Frontiers in Oncology, and member of the Editorial Board for Blood Advances and serves as an ad-hoc or recurrent peer-reviewer for numerous high-profile journals, such as Blood and JAMA Oncology. He is recipient of several awards including the 2022-2025 Lymphoma Research Foundation Career Development Award, and 2022 Memorial Sloan-Kettering Steven A. Greenberg Lymphoma Research Award.